Differentiating erythrasma from other diseases: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Erythrasma}} {{CMG}}; {{AE}} {{LRO}} ==Overview== Erythrasma must be differentiated from other dermatological conditions that present with pain, erythem...")
 
No edit summary
Line 17: Line 17:
| style="padding: 5px 5px; background: #F5F5F5;" |Presents with [[erythema]] and formation of silvery scales on the [[epidermis]], resulting in [[itching]] and [[pain]].<ref name="urlPsoriasis: MedlinePlus">{{cite web |url=https://medlineplus.gov/psoriasis.html |title=Psoriasis: MedlinePlus |format= |work= |accessdate=}}</ref> Differentiates from Erythrasma in that it is usually located throughout the entire body; Erythrasma usually manifests in [[skin]] folds of the [[armpit]], [[groin]], and [[perianal]] regions.<ref name="pmid25085957">{{cite journal |vauthors=Di Meglio P, Villanova F, Nestle FO |title=Psoriasis |journal=Cold Spring Harb Perspect Med |volume=4 |issue=8 |pages= |year=2014 |pmid=25085957 |pmc=4109580 |doi=10.1101/cshperspect.a015354 |url=}}</ref>Psoriasis is an [[autoimmune]] disorder and is not caused by [[Corynebacteria]]; therapeutic options include topical [[corticosteroids]], systemic anti-[[inflammatory]] therapies (such as [[methotrexate]] and [[cyclosporine]]), and [[UVA]]/[[UVB]] [[phototherapy]].<ref name="pmid25085957">{{cite journal |vauthors=Di Meglio P, Villanova F, Nestle FO |title=Psoriasis |journal=Cold Spring Harb Perspect Med |volume=4 |issue=8 |pages= |year=2014 |pmid=25085957 |pmc=4109580 |doi=10.1101/cshperspect.a015354 |url=}}</ref> Psoriasis is a chronic, recurrent condition; Erythrasma will usually resolve with sufficient treatment.
| style="padding: 5px 5px; background: #F5F5F5;" |Presents with [[erythema]] and formation of silvery scales on the [[epidermis]], resulting in [[itching]] and [[pain]].<ref name="urlPsoriasis: MedlinePlus">{{cite web |url=https://medlineplus.gov/psoriasis.html |title=Psoriasis: MedlinePlus |format= |work= |accessdate=}}</ref> Differentiates from Erythrasma in that it is usually located throughout the entire body; Erythrasma usually manifests in [[skin]] folds of the [[armpit]], [[groin]], and [[perianal]] regions.<ref name="pmid25085957">{{cite journal |vauthors=Di Meglio P, Villanova F, Nestle FO |title=Psoriasis |journal=Cold Spring Harb Perspect Med |volume=4 |issue=8 |pages= |year=2014 |pmid=25085957 |pmc=4109580 |doi=10.1101/cshperspect.a015354 |url=}}</ref>Psoriasis is an [[autoimmune]] disorder and is not caused by [[Corynebacteria]]; therapeutic options include topical [[corticosteroids]], systemic anti-[[inflammatory]] therapies (such as [[methotrexate]] and [[cyclosporine]]), and [[UVA]]/[[UVB]] [[phototherapy]].<ref name="pmid25085957">{{cite journal |vauthors=Di Meglio P, Villanova F, Nestle FO |title=Psoriasis |journal=Cold Spring Harb Perspect Med |volume=4 |issue=8 |pages= |year=2014 |pmid=25085957 |pmc=4109580 |doi=10.1101/cshperspect.a015354 |url=}}</ref> Psoriasis is a chronic, recurrent condition; Erythrasma will usually resolve with sufficient treatment.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Necrotizing fasciitis]]'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Dermatophytosis]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |Presents with more severe [[epidermal]] signs and symptoms than erysipelas. Necrotizing fasciitis patients usually present with [[erythema]], [[edema]], [[blisters]], [[pain]], [[suppuration]], and clear signs of [[tissue]] [[necrosis]] (dark violet/blue to black in appearance).<ref name="urlNecrotizing soft tissue infection: MedlinePlus Medical Encyclopedia">{{cite web |url=https://medlineplus.gov/ency/article/001443.htm |title=Necrotizing soft tissue infection: MedlinePlus Medical Encyclopedia |format= |work= |accessdate=}}</ref> Left untreated, [[necrotizing fasciitis]] usually leads to [[subcutaneous]] [[nerve]] destruction; a patient communicating more [[pain]] than is visibly apparent or manifested on the [[epidermis]] is indicative of [[nerve]] damage preceding or disproportionate to visible evidence.<ref name="pmid24459334">{{cite journal |vauthors=Sadasivan J, Maroju NK, Balasubramaniam A |title=Necrotizing fasciitis |journal=Indian J Plast Surg |volume=46 |issue=3 |pages=472–8 |year=2013 |pmid=24459334 |pmc=3897089 |doi=10.4103/0970-0358.121978 |url=}}</ref> In addition to antibiotics, immediate therapeutic surgery is required to prevent morbidity from [[necrotizing fasciitis]].
| style="padding: 5px 5px; background: #F5F5F5;" |Presents with lesions that vary based on the location of the [[mycosis]], but usually displays in a circular shape with [[erythema]], scaling, and [[itching]] at the point of infiltration .<ref name="pmid25403034">{{cite journal |vauthors=Ely JW, Rosenfeld S, Seabury Stone M |title=Diagnosis and management of tinea infections |journal=Am Fam Physician |volume=90 |issue=10 |pages=702–10 |year=2014 |pmid=25403034 |doi= |url=}}</ref>
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Shingles]]'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Shingles]]'''

Revision as of 20:10, 29 September 2016

Erythrasma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Erythrasma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating erythrasma from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Differentiating erythrasma from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating erythrasma from other diseases

on Differentiating erythrasma from other diseases

Differentiating erythrasma from other diseases in the news

Blogs on Differentiating erythrasma from other diseases

Directions to Hospitals Treating Erythrasma

Risk calculators and risk factors for Differentiating erythrasma from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Overview

Erythrasma must be differentiated from other dermatological conditions that present with pain, erythema, edema, and blisters of the skin, as well as other systemic conditions such as fever, chills, fatigue, headache, and vomiting.

Differentiating Erythrasma from other Diseases

Erythrasma must be differentiated from other dermatological conditions that present with reddish-brown scales and [[itching], as well as other diseases resulting from corynebacteria infection.

Disease Findings
Psoriasis Presents with erythema and formation of silvery scales on the epidermis, resulting in itching and pain.[1] Differentiates from Erythrasma in that it is usually located throughout the entire body; Erythrasma usually manifests in skin folds of the armpit, groin, and perianal regions.[2]Psoriasis is an autoimmune disorder and is not caused by Corynebacteria; therapeutic options include topical corticosteroids, systemic anti-inflammatory therapies (such as methotrexate and cyclosporine), and UVA/UVB phototherapy.[2] Psoriasis is a chronic, recurrent condition; Erythrasma will usually resolve with sufficient treatment.
Dermatophytosis Presents with lesions that vary based on the location of the mycosis, but usually displays in a circular shape with erythema, scaling, and itching at the point of infiltration .[3]
Shingles Presents with itching, pain, and tingling on a single side of the body or face, which will develop into a rash with blisters. It can also present with fever, chills, headache, and nausea.[4]. Differentiated from erysipelas by its cause (Varicella zoster virus infection) and is usually self-limited; antiviral therapy and analgesics are indicated to shorten the duration and severity of symptoms, which will usually self-resolve within 7-10 days. Recognition and diagnosis of shingles is important to prevent complications, including postherpetic neuralgia.[5]
Angioedema An edematous condition that involves swelling occurring below the epidermis, including the dermis and mucous membranes.[6] Angioedema usually presents with edema near the eyes and lips, as well as the hands, feet, and throat.[7] Can present similarly to erysipelas if epidermal welts and blisters form in the regions of edema, as well as cause abdominal pain.[8] Differentiated from erysipelas in that the cause is primarily an allergic reaction to a variety of possible allergens, including pollen, food, or medication. While angioedema is usually self-limited and will resolve itself upon the cessation of exposure to the allergen, treatment with antihistamines, epinephrine, or corticosteroids must be administered to prevent life-threatening complications, including asphyxiation if the edema occurs in the throat.[8]
Contact dermatitis An inflammatory condition of the epidermis resulting from direct contact with an allergen or irritant. Contact dermatitis is similar to erysipelas due to the usual presentation of erythema, blisters, itching, pain, and discharge. Differentiated from erysipelas by its cause: an allergic response by contact to a specific surface or entity. There is no indication of bacterial infection. Common causes include chemicals from cosmetic and hygienic products, fabrics, metals, and animal hair or skin. Therapy involves avoiding the original cause and application of topical or oral corticosteroids and analgesics.[9]
Inflammatory breast cancer Presents with edema and erythema of the breast, as well as itching, pain, and tenderness from the inflammation.[10] Differentiated from erysipelas by the fact that inflammation is usually limited to the breast. Additional differential criteria include development of "ridges" on the breast, giving the appearance of an orange peel. It is urgent to differentiate and diagnose inflammatory breast cancer to begin immediate chemotherapy, radiation therapy, and/or surgery when indicated.

References

  1. "Psoriasis: MedlinePlus".
  2. 2.0 2.1 Di Meglio P, Villanova F, Nestle FO (2014). "Psoriasis". Cold Spring Harb Perspect Med. 4 (8). doi:10.1101/cshperspect.a015354. PMC 4109580. PMID 25085957.
  3. Ely JW, Rosenfeld S, Seabury Stone M (2014). "Diagnosis and management of tinea infections". Am Fam Physician. 90 (10): 702–10. PMID 25403034.
  4. "Shingles | Signs and Symptoms | Herpes Zoster | CDC".
  5. Kawai K, Gebremeskel BG, Acosta CJ (2014). "Systematic review of incidence and complications of herpes zoster: towards a global perspective". BMJ Open. 4 (6): e004833. doi:10.1136/bmjopen-2014-004833. PMC 4067812. PMID 24916088.
  6. Misra L, Khurmi N, Trentman TL (2016). "Angioedema: Classification, management and emerging therapies for the perioperative physician". Indian J Anaesth. 60 (8): 534–41. doi:10.4103/0019-5049.187776. PMC 4989802. PMID 27601734.
  7. "Angioedema: MedlinePlus Medical Encyclopedia".
  8. 8.0 8.1 Bork K (2010). "Recurrent angioedema and the threat of asphyxiation". Dtsch Arztebl Int. 107 (23): 408–14. doi:10.3238/arztebl.2010.0408. PMC 2893523. PMID 20589206.
  9. "Contact dermatitis: MedlinePlus Medical Encyclopedia".
  10. "Inflammatory Breast Cancer - National Cancer Institute".

Template:WH Template:WS